Stock PIII P3 HEALTH PARTNERS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Company P3 Health Partners Inc.

Equities

PIII

US7444131053

Biotechnology & Medical Research

Real-time Estimate Cboe BZX
Other stock markets
 15:43:12 2024-06-28 EDT 		5-day change 1st Jan Change
0.484 USD -14.44% Intraday chart for P3 Health Partners Inc. -10.49% -64.35%
05-24 P3 Health Partners Inc. announced that it has received $42.2598 million in funding from Chicago Pacific Founders, Alyeska Investment Group, L.P., Leavitt Equity Partners, Armistice Capital LLC and other investors CI
05-22 P3 Health Partners Inc. announced that it expects to receive $42.2598 million in funding from Chicago Pacific Founders CI

Business Summary

P3 Health Partners Inc. is a patient-centered and physician-led population health management company. The Company supports primary care providers with value-based care coordination and administrative services that improve patient outcomes and lower costs. Through partnerships with these local providers, it creates an enhanced patient experience by navigating, coordinating, and integrating the patient’s care within the healthcare system. Its technology platform, P3 Technology/Health Hub, enables physicians, care teams, patients and their family members to engage in the care journey. P3 Technology/Health Hub integrates clinical and claims data from more than 250 disparate data points each month from payors, outpatient and inpatient facilities and other ancillary care settings. It has a network of more than 2,800 affiliated primary care providers across the country. Its local teams of health care professionals manage the care of thousands of patients in 23 counties across five states.

Number of employees: 400

Sales per Business

USD in Million2022Weight2023Weight Delta
Capitated
98.9 %
1,035 98.6 % 1,252 98.9 % +21.02%
Other Patient Service - Care Coordination / Management Fees
0.7 %
8 0.8 % 8 0.7 % +4.76%
Other Patient Service - Clinical Fees & Insurance
0.4 %
6 0.6 % 5 0.4 % -15.69%
Other Patient Service - Incentive Fees
0.0 %
0 0.0 % 1 0.0 % +140.76%

Sales per region

USD in Million2022Weight2023Weight Delta
United States
100.0 %
1,049 100.0 % 1,266 100.0 % +20.67%

Managers

Managers TitleAgeSince
Sherif Abdou FOU
 Founder 63 20-08-19
Amir Bacchus FOU
 Founder 60 20-08-19
Atul Kavthekar DFI
 Director of Finance/CFO 56 22-12-11
Jeffrey Wagner CTO
 Chief Tech/Sci/R&D Officer - 17-12-31
William Bettermann COO
 Chief Operating Officer - 23-06-19
Devery Goodey CTO
 Chief Tech/Sci/R&D Officer - -
Karen Blomquist IRC
 Investor Relations Contact - 22-04-30
Rich Powers PRN
 Corporate Officer/Principal - -
Sarah Bussmann HRO
 Human Resources Officer - -
Todd Lefkowitz PRN
 Corporate Officer/Principal - -

Members of the board

Members of the board TitleAgeSince
Mary Tolan BRD
 Director/Board Member 63 21-12-02
Gregory Wasson BRD
 Director/Board Member 65 21-12-02
Mark Thierer CHM
 Chairman 64 21-12-02
Jeffrey Park BRD
 Director/Board Member 52 21-12-02
Lawrence Leisure BRD
 Director/Board Member 73 21-12-02
Gregory Kazarian BRD
 Director/Board Member 61 21-12-02
Thomas Price BRD
 Director/Board Member 68 21-12-02
Amir Bacchus FOU
 Founder 60 20-08-19
Sherif Abdou FOU
 Founder 63 20-08-19

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 196,494,420 0 0 75.08 %
Stock B 1 119,620,285 89,806,302 ( 75.08 %) 0

Shareholders

NameEquities%Valuation
Chicago Pacific Capital LP
49.29 %
58,958,539 49.29 % 30 M $
Leavitt Equity Partners LLC
8.225 %
9,838,997 8.225 % 5 M $
Columbia Wanger Asset Management LLC
6.284 %
7,516,643 6.284 % 4 M $
BlackRock Advisors LLC
1.944 %
2,325,253 1.944 % 1 M $
Amir Bacchus
1.886 %
2,256,491 1.886 % 1 M $
Janus Henderson Investors US LLC
1.771 %
2,118,036 1.771 % 1 M $
Sherif Abdou
1.344 %
1,608,225 1.344 % 807 329 $
Vanguard Fiduciary Trust Co.
1.268 %
1,516,678 1.268 % 761 372 $
EMFO LLC
0.8538 %
1,021,271 0.8538 % 512 678 $
Geode Capital Management LLC
0.7603 %
909,478 0.7603 % 456 558 $
NameEquities%Valuation
Walleye Capital LLC
-
3,093,955 - 142 322 $
LMR Partners LLP
-
2,546,924 - 117 159 $
EMFO LLC
-
501,619 - 23 074 $
Cowen & Co. LLC
-
350,947 - 16 144 $
Kim LLC
-
166,666 - 7 667 $
Peak6 Investments LLC
-
141,831 - 6 524 $
Greenland Capital Management LP
-
141,412 - 6 505 $
Moore Capital Management LP
-
133,333 - 6 133 $
Tenor Capital Management Co. LP
-
100,624 - 4 629 $
Walleye Trading LLC
-
98,428 - 4 528 $
NameEquities%Valuation
Chicago Pacific Capital LP
45.18 %
91,269,317 45.18 % 46 M $
Hudson Vegas Investment Manager LLC
21.77 %
43,974,331 21.77 % 22 M $
Sherif Abdou
13.95 %
28,185,982 13.95 % 14 M $
Amir Bacchus
9.301 %
18,790,658 9.301 % 9 M $
Leavitt Equity Partners LLC
3.715 %
7,505,383 3.715 % 4 M $
Gregory Kazarian
0.5829 %
1,177,659 0.5829 % 591 185 $
Thomas Price
0.5829 %
1,177,659 0.5829 % 591 185 $

Company contact information

P3 Health Partners, Inc.

2370 Corporate Circle Suite 300

89074, Henderson

+

http://www.p3hp.org
address P3 Health Partners Inc.(PIII)

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Other Biotechnology & Medical Research

Sales per Business

Ratings for P3 Health Partners Inc.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
4
Last Close Price
0.5657 USD
Average target price
2.7 USD
Spread / Average Target
+377.28%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
P3 HEALTH PARTNERS INC. Stock P3 Health Partners Inc.
-64.35% 91.2M
LONZA GROUP AG Stock Lonza Group AG
+38.65% 39.1B
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
-9.26% 38.76B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
+27.08% 31.24B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+10.79% 25.9B
CELLTRION, INC. Stock Celltrion, Inc.
-13.50% 25.8B
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+43.76% 14.06B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+34.18% 13.12B
BIO-TECHNE CORPORATION Stock Bio-Techne Corporation
-8.24% 11.32B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Stock Charles River Laboratories International, Inc.
-13.21% 10.68B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. PIII Stock
  4. Company P3 Health Partners Inc.